Asperger's Disorder
16
0
0
12
Key Insights
Highlights
Success Rate
86% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
12.5%
2 terminated out of 16 trials
85.7%
-0.8% vs benchmark
25%
4 trials in Phase 3/4
67%
8 of 12 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 12 completed trials
Clinical Trials (16)
Cognitive Neuroscience of Autism Spectrum Disorders
Cognitive-Behavioral Therapy for Irritability in Adolescents With High Functioning Autism Spectrum Disorder
GroundsKeeper: A Qualitative Study of Applied Game-based Interactives in Special Education Programs
Adolescent Social Skills Training Program
Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine
Memantine in Adult Autism Spectrum Disorder
An Open-Label Trial of Aripiprazole in Autism Spectrum Disorders
D-Cycloserine and Social Skills Training in Autism Spectrum Disorders
Atomoxetine, Placebo and Parent Management Training in Autism
An Open-Label Study to Evaluate the Efficacy of High-Dose Gammaplex in Children on the Autism Spectrum
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Janssen Asperger's MRS (Magnetic Resonance Spectroscopy Risperidone Study
An Open-Label Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
A Study of Aripiprazole in Children and Adolescents With Aspergers and Pervasive Developmental Disorder.
Mercury Chelation to Treat Autism
The Use of rTMS to Improve Theory of Mind Among Adults With Autism and Asperger's Disorder